A federal judge has approved a leadership team of 25 lawyers, 18 of whom are women, to lead more than 100 lawsuits brought over the pharmaceutical drug Elmiron. The team includes one attorney from Grant & Eisenhofer’s Wilmington office.

In a Friday order, U.S. District Judge Brian Martinotti of the District of New Jersey approved a slate that the plaintiffs lawyers touted earlier this month as having “significant diversity in gender, ethnicity, geography and experience.”

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]